Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir for genotype 3 HCV in patients with cirrhosis
NCT02087111Phase 4Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2014
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in Hepatitis C, genotype 3, sponsored by Queen Mary University of London. Started Apr 2014; status: completed.
02
Drugs
telaprevir
03
Conditions
Hepatitis C, genotype 3
Beyond the preview
Go deeper on NCT02087111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087111.